Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Volitionrx Ltd

NYSE: VNRX · Life Sciences · 7 alerts · CIK 93314

Share price
$0.1998Close, Nov 16
Market cap
$7.21M
Shares outstanding
36.08MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Volitionrx Ltd filings on SEC EDGAR ↗

5:01 PM ET 8-K
Loan & Debt

Volitionrx $500K Debt Financing with Lind Global Asset Management XII LLC

VolitionRx entered into a waiver and consent agreement with Lind Global Asset Management to make a $500,000 partial cash prepayment on a senior secured convertible promissory note, reducing the outstanding balance to approximately $0.7 million. The agreement also defers monthly repayments for November and December 2026 and pauses Lind's conversion rights until January 1, 2027, unless the stock price reaches $0.275.

Value
$500K
Counterparty
Lind Global Asset Management XII LLC
5:00 PM ET 8-K
Loan & Debt

Volitionrx $525K Debt Financing with Lind Global Asset Management XII LLC

VolitionRx Limited issued an aggregate of 2,157,340 shares of common stock to Lind Global Asset Management XII LLC to satisfy $525,000 in conversion obligations under a senior secured convertible promissory note. The shares were issued in two tranches on September 18 and September 23, 2026, as part of the settlement of an existing debt instrument originally issued in May 2025.

Value
$525K
Counterparty
Lind Global Asset Management XII LLC
5:01 PM ET 8-K
Loan & Debt

Volitionrx Debt Financing Update with Lind Global Asset Management XII LLC

VolitionRx Limited issued a total of 1,413,450 shares of common stock to Lind Global Asset Management XII LLC to satisfy $465,000 in conversion obligations under existing senior secured convertible promissory notes. The shares were issued in two tranches on September 2 and September 10, 2026, as part of the settlement of debt obligations originally established in May 2025.

Counterparty
Lind Global Asset Management XII LLC
4:48 PM ET 8-K
Loan & Debt

Volitionrx Debt Financing Update with Lind Global Asset Management XII LLC

VolitionRx Limited has prepaid in cash the remaining outstanding principal amount of approximately $422,000 on its senior secured convertible promissory note issued in May 2025. Following this payment, no further obligations remain under the 2025 Note, although a separate 2026 Note with Lind Global Asset Management remains in effect. This action reduces the company's outstanding debt and settles the specific 2025 financing obligation.

Counterparty
Lind Global Asset Management XII LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.